Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Samsung Biologics | Seoul | Healthcare | Pharmaceuticals | KRW 80.43T | 67.7x | 6.36 | KRW 1,130,000 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.5% Upside | Upgrade to Pro+ | |
Alteogen | KOSDAQ | Healthcare | Pharmaceuticals | KRW 20.89T | -4,279.7x | 44.94 | KRW 392,000 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.3% Upside | Upgrade to Pro+ | |
Yuhan | Seoul | Healthcare | Pharmaceuticals | KRW 10.18T | 60.5x | 0.65 | KRW 136,000 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.1% Downside | Upgrade to Pro+ | |
Yuhan | Seoul | Healthcare | Pharmaceuticals | KRW 10.18T | 60.5x | 0.65 | KRW 121,100 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sk Biopharma | Seoul | Healthcare | Pharmaceuticals | KRW 9.77T | 144.5x | 1.03 | KRW 124,700 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.5% Upside | Upgrade to Pro+ | |
Sam Chun Dang Pharm | KOSDAQ | Healthcare | Pharmaceuticals | KRW 4.36T | 663.7x | 6.9 | KRW 187,300 | -6.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SK Bioscience Co | Seoul | Healthcare | Pharmaceuticals | KRW 3.83T | -101.7x | 0.45 | KRW 48,850 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.7% Downside | Upgrade to Pro+ | |
Hanmi Pharm Co | Seoul | Healthcare | Pharmaceuticals | KRW 3.34T | 21.3x | 0.91 | KRW 263,500 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.5% Upside | Upgrade to Pro+ | |
Hugel | KOSDAQ | Healthcare | Pharmaceuticals | KRW 2.85T | 28.3x | 0.52 | KRW 258,500 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.4% Upside | Upgrade to Pro+ | |
Pharma Reaserch Products | KOSDAQ | Healthcare | Pharmaceuticals | KRW 2.84T | 30.4x | 1.22 | KRW 273,500 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.5% Upside | Upgrade to Pro+ | |
Celltrion Pharm | KOSDAQ | Healthcare | Pharmaceuticals | KRW 2.27T | 95.3x | KRW 52,100 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Hanall Biopharma | Seoul | Healthcare | Pharmaceuticals | KRW 2.14T | -272.1x | 1.65 | KRW 42,250 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.6% Upside | Upgrade to Pro+ | |
Hanmi Science | Seoul | Healthcare | Pharmaceuticals | KRW 1.9T | 19.3x | 9.58 | KRW 28,100 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ST Pharm | KOSDAQ | Healthcare | Pharmaceuticals | KRW 1.88T | 49.5x | 0.32 | KRW 93,400 | 4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 45.9% Upside | Upgrade to Pro+ | |
Daewoong Pharma | Seoul | Healthcare | Pharmaceuticals | KRW 1.66T | 13.1x | 0.13 | KRW 144,400 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46% Upside | Upgrade to Pro+ | |
GC Biopharma | Seoul | Healthcare | Pharmaceuticals | KRW 1.58T | -102.5x | 0.07 | KRW 138,300 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.9% Upside | Upgrade to Pro+ | |
Caregen | KOSDAQ | Healthcare | Pharmaceuticals | KRW 1.52T | 33.4x | -11.11 | KRW 31,000 | -8.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.8% Upside | Upgrade to Pro+ | |
HLB Life Science | KOSDAQ | Healthcare | Pharmaceuticals | KRW 1.22T | 14.6x | 0.09 | KRW 10,040 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oscotec | KOSDAQ | Healthcare | Pharmaceuticals | KRW 1.1T | -226.6x | -3.1 | KRW 28,550 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nature Cell | KOSDAQ | Healthcare | Pharmaceuticals | KRW 1.09T | -258.4x | 0.3 | KRW 16,910 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chong Kun Dang Pharma | Seoul | Healthcare | Pharmaceuticals | KRW 1.09T | 6.4x | 0.15 | KRW 82,500 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HK Inno.N | KOSDAQ | Healthcare | Pharmaceuticals | KRW 1.04T | 25.6x | KRW 36,750 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Mezzion Pharma | KOSDAQ | Healthcare | Pharmaceuticals | KRW 882.42B | -68.1x | -1.34 | KRW 29,200 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Daewoong | Seoul | Healthcare | Pharmaceuticals | KRW 881.19B | 6.8x | 2.97 | KRW 21,550 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.7% Upside | Upgrade to Pro+ | |
Boryung Pharm | Seoul | Healthcare | Pharmaceuticals | KRW 857.26B | 10.5x | 0.12 | KRW 10,210 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.6% Upside | Upgrade to Pro+ | |
HLB Therapeutics | KOSDAQ | Healthcare | Pharmaceuticals | KRW 847.15B | -31.2x | 0.06 | KRW 10,110 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medy-Tox | KOSDAQ | Healthcare | Pharmaceuticals | KRW 788.48B | 78.8x | 4.91 | KRW 118,400 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Binex | KOSDAQ | Healthcare | Pharmaceuticals | KRW 697.46B | -22.5x | 0.03 | KRW 21,900 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.8% Upside | Upgrade to Pro+ | |
Dongkook Pharmaceutical | KOSDAQ | Healthcare | Pharmaceuticals | KRW 683.27B | 11.3x | 0.37 | KRW 15,540 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47% Upside | Upgrade to Pro+ | |
Green Cross Holdings | Seoul | Healthcare | Pharmaceuticals | KRW 663.48B | -11.2x | 0.01 | KRW 22,800 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Cross | Seoul | Healthcare | Pharmaceuticals | KRW 663.48B | -11.2x | 0.01 | KRW 14,570 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Donga Socio Holdings | Seoul | Healthcare | Pharmaceuticals | KRW 626.95B | 11.2x | 0.21 | KRW 100,300 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
JW Pharmaceutical | Seoul | Healthcare | Pharmaceuticals | KRW 588.43B | 20.6x | -0.12 | KRW 30,000 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jw Pharmac | Seoul | Healthcare | Pharmaceuticals | KRW 588.43B | 20.6x | -0.12 | KRW 23,500 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
JW Pharmaceutical | Seoul | Healthcare | Pharmaceuticals | KRW 588.43B | 20.6x | -0.12 | KRW 60,200 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharmicell | Seoul | Healthcare | Pharmaceuticals | KRW 581.44B | -11.6x | KRW 9,690 | 9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Shinpoong Phar | Seoul | Healthcare | Pharmaceuticals | KRW 534.32B | -16.6x | -0.88 | KRW 10,200 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shinpoong Pharmaceutical Co | Seoul | Healthcare | Pharmaceuticals | KRW 534.32B | -16.6x | -0.88 | KRW 15,950 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dong-A St | Seoul | Healthcare | Pharmaceuticals | KRW 458.16B | -6.2x | 0.01 | KRW 51,000 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivozon Healthcare | KOSDAQ | Healthcare | Pharmaceuticals | KRW 451.33B | -181.9x | -1.58 | KRW 9,140 | 13.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Huons Global | KOSDAQ | Healthcare | Pharmaceuticals | KRW 446.4B | 12x | 0.07 | KRW 37,850 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eubiologics | KOSDAQ | Healthcare | Pharmaceuticals | KRW 418.68B | -32x | KRW 11,460 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Humedix | KOSDAQ | Healthcare | Pharmaceuticals | KRW 373.69B | 37.1x | KRW 36,250 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Yungjin Pharm | Seoul | Healthcare | Pharmaceuticals | KRW 373.1B | 37.9x | KRW 2,040 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Prestige Biologics Co | KOSDAQ | Healthcare | Pharmaceuticals | KRW 362.31B | -12.3x | KRW 4,680 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
BioPlus | KOSDAQ | Healthcare | Pharmaceuticals | KRW 357.05B | 22.6x | -0.74 | KRW 6,220 | -4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB Pharmaceutical | KOSDAQ | Healthcare | Pharmaceuticals | KRW 345.44B | 644.6x | KRW 24,600 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Bukwang Pharm | Seoul | Healthcare | Pharmaceuticals | KRW 325.16B | -21x | -0.93 | KRW 4,750 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Il Dong Pharma | Seoul | Healthcare | Pharmaceuticals | KRW 319.27B | -29x | -0.32 | KRW 11,430 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Huons | KOSDAQ | Healthcare | Pharmaceuticals | KRW 307.67B | 9.7x | -0.36 | KRW 26,050 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |